Page last updated: 2024-08-23

lithium and Anterior Choroidal Artery Infarction

lithium has been researched along with Anterior Choroidal Artery Infarction in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Ates, N; Balcikanli, Z; Beker, MC; Caglayan, A; Caglayan, AB; Caglayan, B; Celik, S; Dasdelen, MF; Dilsiz, P; Doeppner, TR; Hermann, DM; Kilic, E; Ozbek, H; Sertel, E; Yigitbasi, T1
Chen, RW; Chuang, DM; Ren, M; Senatorov, VV1
Abe, K; Mizuki, T; Ohji, T; Terao, T1
Heigl, B; Heigl, F; Hiller, E; Kampfhammer, HP; Steinbeck, G1
Chuang, DM; Nonaka, S1
Ahuja, GK; Balaraju, KB1

Other Studies

6 other study(ies) available for lithium and Anterior Choroidal Artery Infarction

ArticleYear
Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice.
    Experimental neurology, 2022, Volume: 351

    Topics: Animals; Apoptosis; Brain Ischemia; Cerebral Infarction; Glycogen Synthase Kinase 3 beta; Lithium; Mice; Mitogen-Activated Protein Kinase Kinases; Neuroprotection; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Stroke

2022
Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model.
    Proceedings of the National Academy of Sciences of the United States of America, 2003, May-13, Volume: 100, Issue:10

    Topics: Animals; Apoptosis; Blood Pressure; Body Temperature; Brain Damage, Chronic; Cerebral Infarction; Cerebrovascular Circulation; Ischemic Attack, Transient; Lithium; Male; Rats; Rats, Sprague-Dawley; Reflex, Startle; Reperfusion

2003
Antidepressant effect of lithium in patients with systemic lupus erythematosus and cerebral infarction, treated with corticosteroid.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cerebral Infarction; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lithium; Lupus Erythematosus, Systemic; Mianserin; Neurocognitive Disorders; Prednisolone; Substance-Related Disorders

1994
[Chronic recurrent thrombotic thrombocytopenic purpura (Moschcowitz disease). An unusual long-term course in a 43-year-old patient].
    Der Internist, 1993, Volume: 34, Issue:10

    Topics: Adult; Aspirin; Biopsy; Cerebral Angiography; Cerebral Infarction; Combined Modality Therapy; Female; Follow-Up Studies; Gingiva; Humans; Lithium; Perazine; Plasma; Purpura, Thrombotic Thrombocytopenic; Recurrence

1993
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
    Neuroreport, 1998, Jun-22, Volume: 9, Issue:9

    Topics: Animals; Blood Gas Analysis; Cerebral Infarction; Ischemic Attack, Transient; Lithium; Neuroprotective Agents; Rats; Rats, Wistar

1998
Prior neurologic illness and the syndrome of irreversible lithium-effectuated neurotoxicity (SILENT).
    The Australian and New Zealand journal of psychiatry, 1989, Volume: 23, Issue:3

    Topics: Adult; Bipolar Disorder; Cerebral Infarction; Diagnosis, Differential; Dose-Response Relationship, Drug; Hemiplegia; Humans; Lithium; Male; Psychoses, Substance-Induced

1989